MetaADEDB 2.0 @ LMMD
Acidum gadopenteticum
(IZOOGPBRAOKZFK-UHFFFAOYSA-K)
Structure
SMILES
[O-]C(=O)CN(CCN(CC(=O)O)CC(=O)[O-])CCN(CC(=O)O)CC(=O)[O-].[Gd+3]
Type(s)
Approved
ATC code(s)
V08CA01
Molecular Formula:
C14H20GdN3O10
Molecular Weight:
547.573
Log P:
-6.6887
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
2
TPSA:
204.71
CAS Number(s):
80529-93-7
Synonym(s)
1.
Acidum gadopenteticum
2.
Gadopentetate
3.
2-[2-[Bis(carboxylatomethyl)amino]ethyl-[2-[bis(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+)
4.
2-[2-[2-[Bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate;gadolinium(3+)
5.
Gadopentetic acid
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Contrast media reactionFAERS: 1US FAERS
2Feeling abnormalFAERS: 1US FAERS
3NauseaFAERS: 1SIDER
US FAERS
4Abdominal PainSIDER
5Abdominal discomfortSIDER
6AgitationSIDER
7Anaphylactic shockSIDER
8Anaphylactoid ReactionSIDER
9AngioedemaSIDER
10AnxietySIDER
11ArthralgiaSIDER
12AstheniaSIDER
13Back PainSIDER
14BradycardiaSIDER
15BronchospasmSIDER
16Burning sensationSIDER
17Cardiac ArrestSIDER
18Chest PainSIDER
19Chest discomfortSIDER
20Chest tightnessSIDER
21ChillsSIDER
22ConjunctivitisSIDER
23CyanosisSIDER
24DeafnessSIDER
25Deep Vein ThrombosisSIDER
26DermatitisSIDER
27DiplopiaSIDER
28DizzinessSIDER
29DysgeusiaSIDER
30Ear and labyrinth disordersSIDER
31Erythema MultiformeSIDER
32Eye irritationSIDER
33Eye painSIDER
34FatigueSIDER
35Feeling ColdSIDER
36Gastrointestinal PainSIDER
37HeadacheSIDER
38HypersensitivitySIDER
39HypotensionSIDER
40Injection Site ReactionSIDER
41Injection site coldnessSIDER
42LacrimationSIDER
43LaryngospasmSIDER
44Musculoskeletal discomfortSIDER
45Nephrogenic Systemic FibrosisSIDER
46PainSIDER
47PallorSIDER
48PhlebitisSIDER
49PruritusSIDER
50Respiratory arrestSIDER
51Respiratory distressSIDER
52Retrosternal painSIDER
53RhinitisSIDER
54ShiveringSIDER
55ShockSIDER
56SneezingSIDER
57Soft tissue necrosisSIDER
58SomnolenceSIDER
59SweatingSIDER
60SyncopeSIDER
61TachycardiaSIDER
62ThirstSIDER
63Throat irritationSIDER
64ThrombophlebitisSIDER
65TremorSIDER
66Urinary IncontinenceSIDER
67UrticariaSIDER
68Visual ImpairmentSIDER
69Visual disturbanceSIDER
70VomitingSIDER
71nervous system disorderSIDER
72pustuleSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.